Evidence map›Paper›PMID 35397694›Full record

ReviewCellular and molecular life sciences : CMLS2022

Circulating cell-specific extracellular vesicles as biomarkers for the diagnosis and monitoring of chronic liver diseases.

Lauren A Newman, Kate Muller, Andrew Rowland

Open access · hybridAbstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 48 citations in OpenAlex.

  1. Special Issue "Novel Targeted Therapies and Drugs in Cancer".International journal of molecular sciences · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Circulating Liver-Derived and CD36Journal of extracellular vesicles · 2026
    Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Lauren A NewmanDepartment of Clinical Pharmacology, College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.ORCID http://orcid.org/0000-0003-3303-1666
Kate MullerDepartment of Gastroenterology and Hepatology, College of Medicine and Public Health, Flinders Medical Centre, Adelaide, SA, Australia.
Andrew RowlandDepartment of Clinical Pharmacology, College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia. andrew.rowland@flinders.edu.au.ORCID http://orcid.org/0000-0002-8946-3954
Flinders University · AUFlinders Medical Centre · AU

Funding

Cancer Council South Australia MCRFNational Health and Medical Research Council of Australia 1158210
6 · The paper itself

Abstract

Chronic liver diseases represent a burgeoning health problem affecting billions of people worldwide. The insufficient performance of current minimally invasive tools is recognised as a significant barrier to the clinical management of these conditions. Extracellular vesicles (EVs) have emerged as a rich source of circulating biomarkers closely linked to pathological processes in originating tissues. Here, we summarise the contribution of EVs to normal liver function and to chronic liver pathologies; and explore the use of circulating EV biomarkers, with a particular focus on techniques to isolate and analyse cell- or tissue-specific EVs. Such approaches present a novel strategy to inform disease status and monitor changes in response to treatment in a minimally invasive manner. Emerging technologies that support the selective isolation and analysis of circulating EVs derived only from hepatic cells, have driven recent advancements in EV-based biomarker platforms for chronic liver diseases and show promise to bring these techniques to clinical settings.

Indexed as

Extracellular VesiclesLiver DiseasesBiomarkersHepatocytesHumansBiomarkersChronic liver diseaseExtracellular vesiclesMetabolic-associated fatty liver diseaseMinimally invasive biomarkersNon-alcoholic fatty liver diseaseTissue-specific biomarkers

Identifiers

PMID35397694
PMCPMC8995281
OpenAlexW4223644595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.